149 related articles for article (PubMed ID: 12200235)
61. Estrogen receptor-alpha and -beta regulate the human corticotropin-releasing hormone gene through similar pathways.
Chen XN; Zhu H; Meng QY; Zhou JN
Brain Res; 2008 Aug; 1223():1-10. PubMed ID: 18597742
[TBL] [Abstract][Full Text] [Related]
62. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription.
Bollig A; Miksicek RJ
Mol Endocrinol; 2000 May; 14(5):634-49. PubMed ID: 10809228
[TBL] [Abstract][Full Text] [Related]
63. Putative functional characteristics of human estrogen receptor-beta isoforms.
Peng B; Lu B; Leygue E; Murphy LC
J Mol Endocrinol; 2003 Feb; 30(1):13-29. PubMed ID: 12580758
[TBL] [Abstract][Full Text] [Related]
64. Bending of the estrogen response element by polyamines and estrogen receptors alpha and beta: a fluorescence resonance energy transfer study.
Vijayanathan V; Thomas TJ; Nair SK; Shirahata A; Gallo MA; Thomas T
Int J Biochem Cell Biol; 2006; 38(7):1191-1206. PubMed ID: 16767802
[TBL] [Abstract][Full Text] [Related]
65. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens.
Hall JM; McDonnell DP
Endocrinology; 1999 Dec; 140(12):5566-78. PubMed ID: 10579320
[TBL] [Abstract][Full Text] [Related]
66. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
67. Differential SERM activation of the estrogen receptors (ERalpha and ERbeta) at AP-1 sites.
Weatherman RV; Clegg NJ; Scanlan TS
Chem Biol; 2001 May; 8(5):427-36. PubMed ID: 11358690
[TBL] [Abstract][Full Text] [Related]
68. Mechanisms of transcriptional activation of the mouse claudin-5 promoter by estrogen receptor alpha and beta.
Burek M; Steinberg K; Förster CY
Mol Cell Endocrinol; 2014 Jul; 392(1-2):144-51. PubMed ID: 24846172
[TBL] [Abstract][Full Text] [Related]
69. The agonist activity of tamoxifen is inhibited by the short heterodimer partner orphan nuclear receptor in human endometrial cancer cells.
Klinge CM; Jernigan SC; Risinger KE
Endocrinology; 2002 Mar; 143(3):853-67. PubMed ID: 11861507
[TBL] [Abstract][Full Text] [Related]
70. Cross-inhibition of both estrogen receptor alpha and beta pathways by each dominant negative mutant.
Ogawa S; Inoue S; Orimo A; Hosoi T; Ouchi Y; Muramatsu M
FEBS Lett; 1998 Feb; 423(2):129-32. PubMed ID: 9512344
[TBL] [Abstract][Full Text] [Related]
71. The ligand-mediated nuclear mobility and interaction with estrogen-responsive elements of estrogen receptors are subtype specific.
Muyan M; Callahan LM; Huang Y; Lee AJ
J Mol Endocrinol; 2012 Dec; 49(3):249-66. PubMed ID: 23014840
[TBL] [Abstract][Full Text] [Related]
72. Interactions of estrogen- and thyroid hormone receptors on a progesterone receptor estrogen response element (ERE) sequence: a comparison with the vitellogenin A2 consensus ERE.
Scott RE; Wu-Peng XS; Yen PM; Chin WW; Pfaff DW
Mol Endocrinol; 1997 Oct; 11(11):1581-92. PubMed ID: 9328341
[TBL] [Abstract][Full Text] [Related]
73. Estrogen receptors alpha and beta in rat decidua cells: cell-specific expression and differential regulation by steroid hormones and prolactin.
Tessier C; Deb S; Prigent-Tessier A; Ferguson-Gottschall S; Gibori GB; Shiu RP; Gibori G
Endocrinology; 2000 Oct; 141(10):3842-51. PubMed ID: 11014241
[TBL] [Abstract][Full Text] [Related]
74. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators.
Cho H; Katzenellenbogen BS
Mol Endocrinol; 1993 Mar; 7(3):441-52. PubMed ID: 7683375
[TBL] [Abstract][Full Text] [Related]
75. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
[TBL] [Abstract][Full Text] [Related]
76. Tamoxifen agonism and estrogen antagonism of c-fos gene promoter activity through non-consensus-responsive elements in MC3T3-E1 osteoblasts.
Ishibashi O; Yamagishi T; Hanada K; Kawashima H
Biochem Biophys Res Commun; 2001 Dec; 289(3):705-11. PubMed ID: 11726205
[TBL] [Abstract][Full Text] [Related]
77. Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression.
Harrington WR; Sheng S; Barnett DH; Petz LN; Katzenellenbogen JA; Katzenellenbogen BS
Mol Cell Endocrinol; 2003 Aug; 206(1-2):13-22. PubMed ID: 12943986
[TBL] [Abstract][Full Text] [Related]
78. Fatty acids derived from royal jelly are modulators of estrogen receptor functions.
Moutsatsou P; Papoutsi Z; Kassi E; Heldring N; Zhao C; Tsiapara A; Melliou E; Chrousos GP; Chinou I; Karshikoff A; Nilsson L; Dahlman-Wright K
PLoS One; 2010 Dec; 5(12):e15594. PubMed ID: 21203528
[TBL] [Abstract][Full Text] [Related]
79. The role of the C-terminal extension (CTE) of the estrogen receptor alpha and beta DNA binding domain in DNA binding and interaction with HMGB.
Melvin VS; Harrell C; Adelman JS; Kraus WL; Churchill M; Edwards DP
J Biol Chem; 2004 Apr; 279(15):14763-71. PubMed ID: 14739282
[TBL] [Abstract][Full Text] [Related]
80. Calmodulin is a selective modulator of estrogen receptors.
García Pedrero JM; Del Rio B; Martínez-Campa C; Muramatsu M; Lazo PS; Ramos S
Mol Endocrinol; 2002 May; 16(5):947-60. PubMed ID: 11981030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
